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ABSTRACT 
A series of 2,4- and 4,6-diaminopyrimidines were prepared and evaluated for their in vitro antimalarial 
activity. Of the 12 compounds tested 7 showed reasonable activity with 1 having a sub-micromolar 
IC50. 
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INTRODUCTION 
Malaria is a growing disease that is a major health threat in over 100 countries world wide [1] infecting 
more than 500 million people per year with 2.7 million associated deaths [2]. Of the four parasitic 
strains that infect humans Plasmodium falciparum is the most virulent [3]. Over the past 3 decades 
drug resistant strains of P. falciparum have been increasing at such rate that in 1998 this parasite 
showed reduced susceptibility to at least one drug in almost all cases [4]. The increase in drug resistant 
strains has resulted in a clear requirement for new drugs with novel  modes of action to be discovered. 
 
RESULTS 
Recent work in our laboratory has focused upon the synthesis and biological evaluation of a series of 
diaminopyrimidines as potential antimalarial agents. There are numerous examples of pyrimidine-
based structures showing antimalarial activity including pyrimidine-2,4-dione derivatives (1) [5], 2,4,6-
trisubstituted pyrimidines (2) [6], and the drug pyrimethamine (3) [6] Fig. (1). The mechanism of 
action of pyrimethamine is known to be inhibition of dihydrofolate reductase (DHFR), which prevents 
DNA biosynthesis leading to cell death [6]. 
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Figure 1. Known pyrimidine containing anti-malarial agents including drug pyrimethamine 3 [5,6] 
 
The 2,4- and 4,6-diaminopyrimidine compounds were prepared via two sequential substitution 
reactions of dichloropyrimidine with substituted amines; an example reaction is outlined in Scheme 1 
[7]. 
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(i) 2,4,6-trimethylaniline, H2O, Δ, 35%; (ii) allylamine, Δ, 88%  
Scheme 1. Synthetic pathway for the preparation of 2,4-diaminopyrimidine 
 
Twelve of these diaminopyrimidine derivatives were evaluated for antimalarial activity against P. 
falciparum, with results summarized in Table 1. Of the 12 diaminopyrimidine derivatives 7 have shown 
IC50 values of less than 15 μM and two of these have an IC50 of 1 μM (0.3 μg/ml) or less which is 30 
times more potent than pyrimethamine (3). 
 
Table 1. The structure and antimalarial activity (IC50, μg/ml) of a range of aminopyrimidine 
derivatives. 
Comp Structure IC50 (μg/ml) IC50 (μM)  Comp Structure IC50 (μg/ml) IC50 (μM) 
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Using this biological data a preliminary structure-activity relationship (SAR) can be examined Fig. (2). 
The incorporation of cyclohexylamine instead of a substituted aniline [as in compounds (13)-(16)] 
results in a significant increase in activity. This suggests that associated potential hydrophobic 
interactions may require flexibility of the substrate. Increased substitution of the cyclohexyl group also 
results in an increase in activity. The favoured positions for the nitrogen atoms of the pyrimidine ring is 
either side of the disubstituted amino moiety (positions 1 and 3). However, due to the preliminary 
nature of the SAR study it not possible to determine the preferred substitution at positions 4 or 6. 
 
 
 
Figure 2. Preliminary structure-activity relationship study on 2,4-diaminopyrimidine compounds 
possessing antimalarial activity. 
 
CONCLUSIONS 
Seven compounds with antimalarial activity have been identified and utilized to develop a preliminary 
SAR. These compounds will be useful leads for further optimization in the quest to find new 
antimalarial agents. 
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BIOLOGICAL TESTING 
The parasite P. falciparum (K1, multidrug-resistant strain) was cultured continuously according to the 
method of Trager and Jensen [8]. Quantitative assessment of anti-plasmodial activity in vitro was 
undertaken by means of the microculture radioisotope technique based upon the method described by 
Desjardins et al [9]. Inhibition concentration (IC50) represents the concentration which causes 50% 
reduction in parasite growth as indicated by the uptake of [3H]-hypoxanthine by P. falciparum. 
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